A reactive monocyte subset characterized by low expression of CD91 is expanded during sterile and septic inflammation

Clin Chem Lab Med. 2024 Jan 25;62(7):1438-1449. doi: 10.1515/cclm-2023-0992. Print 2024 Jun 25.

Abstract

Objectives: This study was undertaken to assess CD91 expression on monocytes and changes in monocyte subset distribution during acute tissue damage and bloodstream infection (BSI).

Methods: We investigated blood specimens from healthy individuals, trauma and cardiac surgery patients as a model of tissue damage, and patients with BSI, by flow cytometry using a panel of antibodies comprising CD45, HLA-DR, CD14, CD16 and CD91 for the identification of monocyte subsets.

Results: While infrequent in healthy subjects, CD91low/neg monocyte levels were markedly high in BSI, trauma and after cardiac surgery. This monocyte subset expanded up to 15-fold in both patient cohorts, whereas CD14+CD16+ inflammatory monocytes were multiplied by a factor of 5 only. CD14+CD91low monocytes displayed a significantly lower density of HLA-DR and markedly reduced expression of CD300e, compared to the other subsets. They also expressed high levels of myeloperoxidase and showed robust phagocytic and oxidative burst activity.

Conclusions: Expansion of CD91low monocytes is a sensitive marker of acute inflammatory states of infectious and non-infectious etiology.

Keywords: CD91; bloodstream infection (BSI); flow cytometry; inflammation; monocytes; sepsis.

MeSH terms

  • Adult
  • Aged
  • Female
  • Flow Cytometry
  • HLA-DR Antigens / metabolism
  • Humans
  • Inflammation*
  • Low Density Lipoprotein Receptor-Related Protein-1
  • Male
  • Middle Aged
  • Monocytes* / immunology
  • Monocytes* / metabolism
  • NADPH Oxidase 2 / metabolism
  • Receptors, Complement 3b
  • Receptors, IgG / blood
  • Receptors, IgG / metabolism
  • Sepsis* / blood
  • Sepsis* / immunology

Substances

  • HLA-DR Antigens
  • NADPH Oxidase 2
  • Receptors, Complement 3b
  • Receptors, IgG
  • CR1 protein, human
  • LRP1 protein, human
  • Low Density Lipoprotein Receptor-Related Protein-1